To hear about similar clinical trials, please enter your email below
Trial Title:
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
NCT ID:
NCT06280040
Condition:
Uveal Melanoma
Conditions: Official terms:
Melanoma
Uveal Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Clinical examination and multimodal ocular imaging
Description:
Imaging consists of sonography, fundus photography, oximeter, optical coherence
tomography angiography, and Microperimetry.
Arm group label:
Uveal Melanoma
Summary:
The purpose of this study is to evaluate the incidence and severity of retinopathy and
opticopathy one year after treatment with hypofractionated stereotactic photon
radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as
3, 6, 9 and 12 months after radiation using sonography funds photography, optical
coherence tomography angiography, oximeter and microperimetry.
Criteria for eligibility:
Study pop:
Patients with newly diagnosed uveal melanoma, who will be treated with hypofractionated
stereotactic photon radiotherapy as part of clinical routine, will be included in the
study.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients with newly diagnosed uveal melanoma, who will be treated with
hypofractionated stereotactic photon radiotherapy as part of clinical routine.
Exclusion Criteria:
- unwillingness to participate in the study
- severe media opacity
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Ophthalmology and Optometry, Medical University Vienna
Address:
City:
Vienna
Zip:
1090
Country:
Austria
Status:
Recruiting
Contact:
Last name:
Judith Kreminger, MD
Phone:
0043 1 40400 48470
Email:
judith.kreminger@meduniwien.ac.at
Contact backup:
Last name:
Reinhard Told, MD, PhD, Priv.-Doz.
Phone:
0043 1 40400 48470
Email:
reinhard.told@meduniwien.ac.at
Investigator:
Last name:
Adrian Reumueller, MD, Priv.-Doz
Email:
Sub-Investigator
Investigator:
Last name:
Roman Dunavoelgyi, MD, Assoc.-Prof.
Email:
Sub-Investigator
Start date:
November 23, 2023
Completion date:
June 30, 2025
Lead sponsor:
Agency:
Medical University of Vienna
Agency class:
Other
Source:
Medical University of Vienna
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06280040
